A Retrospective Cohort Study on the Efficacy of Pregabalin in Patients With Sensitive Skin

Authors
Han-Bi Kim, Min-Gyu Choi, Hyung-Woo Jo, Ji-Young Um, So-Yeon Lee, Bo-Young Chung, Chun-Wook Park, Hye-One Kim


Lab
The Hospital Anxiety and Depression Scale

Journal
Contact Dermatitis

Abstract
At 12 weeks, 46.4% of patients responded. Most patients (86.6%) received less than 75 mg/day. Higher baseline SS-10 scores (r= 0.5) and tingling symptoms (p= 0.050) were associated with greater response, while discomfort was associated with non-response (p= 0.005). SS-10 scores correlated with DLQI (r= 0.49) and total HADS (r= 0.29). Reduced von Frey thresholds (r= −0.28) and increased facial erythema (r= 0.39) were observed in responders.

Keywords/Topics
dermatology life quality index (DLQI); neuropathic pain; pregabalin; sensitive skin syndrome (SSS)

BIOSEB Instruments Used:
Von Frey Filaments (BIO-VF-M)

Source :

https://onlinelibrary.wiley.com/doi/abs/10.1111/cod.70063

Related products

Von Frey Filaments

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.